Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Redesigned OR Process and Sugammadex for Efficiency
NCT01937247Phase 3Completed
- Sponsor
- American University of Beirut Medical Center
- Start
- May 2018
- Primary completion
- Oct 2020
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Sugammadex, sponsored by American University of Beirut Medical Center. Started May 2018; status: completed.
02
Drugs
Sugammadex
Beyond the preview
Go deeper on NCT01937247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01937247.